Improving Stem Cell Transplant Success Rates – Nanalyze
Nanalyze |
Improving Stem Cell Transplant Success Rates
Nanalyze Founded in 2016, Massachusetts startup Magenta Therapeutics has taken in just over $150 million in funding from a whole slew of investors including Google Ventures. In short, Magenta is setting out to improve the survival rates for stem cell transplants. |
